Thrombotic microangiopathy after renal transplantation in the United States1 1The opinions expressed are solely those of the authors and do not represent an endorsement by the Department of Defense or the National Institutes of Health.This is a US government work. There are no restrictions on its use.

This publication has 38 references indexed in Scilit:

• Donor Hepatitis C Seropositivity
  Journal of the American Society of Nephrology, 2002
• Hospitalized avascular necrosis after renal transplantation in the United States
  Kidney International, 2002
• Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation
  Pediatric Nephrology, 2002
• Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipient
  Transplantation, 2002
• Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
  British Journal of Haematology, 2002
• Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus
  Transplant International, 2000
• Hemolytic Uremic Syndrome: Recurrence after Renal Transplantation
  Medicine, 2000
• De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection
  American Journal of Kidney Diseases, 1999
• Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura in a Patient with Behçet’s Disease Treated with Cyclosporin
  Nephron, 1997
• Thrombotic microangiopathies
  Critical Reviews in Oncology/Hematology, 1991